🌳Antidumping Duty Review on Wood Products from China
The U.S. Department of Commerce (Commerce) preliminarily determines that exporters subject to this review made sales of subject merchandise at less than normal value during the period of review (POR), February 1, 2023, through January 31, 2024. Further, Commerce is also rescinding this review with respect to 20 of the 38 companies/ company groupings under review. Interested parties are invited to comment on these preliminary results of review.
Learn More🌱EPA Updates Chlorpyrifos Cancellation Order for Asparagus Use
On June 24, 2024, the Environmental Protection Agency (EPA or the Agency) issued a final cancellation order pursuant to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) terminating several food uses on registered chlorpyrifos products, the majority of which were voluntarily requested by Gharda Chemicals International, Inc. (Gharda) and accepted by the Agency. Upon further review of that order, EPA identified an error, which it is correcting in this document. Specifically, EPA is rescinding the termination of asparagus use in the state of Michigan for Pilot 4E Chlorpyrifos Agricultural Insecticide, EPA Reg. No. 93182-7, as Gharda did not request termination of that use.
Learn More📊OMB Review Notice on Cost Accounting Standards Administration
Under the provisions of the Paperwork Reduction Act, the Regulatory Secretariat Division has submitted to OMB a request to review and approve an extension of a previously approved information collection requirement regarding cost accounting standards administration.
Learn More💡Licensing Opportunities for Government-Owned Influenza Inventions
The invention listed below is owned by an agency of the U.S. Government and is available for licensing to achieve expeditious commercialization of results of federally funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing.
Learn More💊FDA Notice on BRIUMVI Patent Extension Implications
The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for BRIUMVI and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of applications to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that human biological product.
Learn More📈Cboe Rule Change to Extend Trading Hours for Expiring Options
The SEC approved a rule change by Cboe Exchange to allow certain A.M.-settled index options to trade during Global Trading Hours leading to their expiration. This modification aims to enhance risk management for market participants, providing more trading opportunities right before settlement and aligning with global market dynamics.
Learn More🏦Change in Bank Control Notices
The Federal Reserve System has issued notice regarding applications for acquiring shares of banks or bank holding companies under the Change in Bank Control Act. Interested parties can comment on these applications, with disclosures on public comments. The document highlights the regulatory framework guiding bank control changes, ensuring transparency in acquisitions.
Learn More💉Overview of the National Vaccine Injury Compensation Program
HRSA is publishing this notice of petitions received under the National Vaccine Injury Compensation Program (the Program), as required by the Public Health Service (PHS) Act, as amended. While the Secretary of HHS is named as the respondent in all proceedings brought by the filing of petitions for compensation under the Program, the United States Court of Federal Claims is charged by statute with responsibility for considering and acting upon the petitions.
Learn More💹MEMX Proposes Non-Display Add Tier 3 Fee Schedule Changes
MEMX LLC filed a proposed rule change with the SEC to amend its fee schedule by introducing a new tier, Non-Display Add Tier 3. This tier aims to enhance rebates for certain executing orders, fostering a competitive trading environment and incentivizing members to increase liquidity. The changes are designed to attract more order flow to the exchange, impacting trading costs and strategies.
Learn More🦺CDC Proposes Data Collection on X-Ray Classifications for Miners
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a proposed information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled X-Ray Classification Collection for Metal and Nonmetal Miners. The purpose of the proposed data collection is to allow medical providers or their staff to submit the B Reader provided classifications of chest radiographs of miners in the metal and nonmetal industry, to better understand the burden of pneumoconiosis in this workforce, as authorized in the Mine Safety and Health Administration (MSHA) final rule for Respirable Crystalline Silica.
Learn More